You searched for "Breathing"

2837 results found

ENT UK Head & Neck Meeting

The ENT UK Head and Neck Evidence-Based Management Meeting focusing on malignancy of the nose and paranasal sinuses was held in the historic market town of York. The multidisciplinary approach required to manage this complex disease was reflected in the speaker lineup, with national representation from ENT, maxillofacial and plastic surgery, oncology, palliative medicine, histopathology and radiology.

European Academy of Otology & Neuro-Otology (EAONO) 2024

Anjola Onifade, SHO Otolaryngology, University Hospitals Sussex, Brighton, UKHeld in Nijmegen, the oldest city of the Netherlands, the conference delivered a dynamic program with thought-provoking presentations and keynote addresses. Focused on advancing the field of otology and neuro-otology, the conference...

BAHNO 2025

From groundbreaking research to a debate on the centralisation of head and neck services, BAHNO provided a wide ranging and clinically enriching programme for all those involved in head and neck oncology care.

The British Acoustic Neuroma Association (BANA) Annual Conference 2025

The British Acoustic Neuroma Association (BANA) will host their Annual Conference this year in Ashover in the Peak District, this year focusing on members’ personal experiences. BANA (British Acoustic Neuroma Association) is a registered charity providing invaluable information and support to people with Acoustic Neuroma / Vestibular Schwannoma (ANVS) and their support networks.

Transoral Laser Microsurgery of Benign and Malignant Lesions

Published in 2016, this is a textbook that I have cited and recommended in a number of talks on transoral laser microsurgery (TLM). The content and layout is very similar to that of Steiner and Ambrosch’s Endoscopic Laser Surgery of...

Sex and the Nose

For regular attentive readers of our little magazine, JRY will need no introduction. The word ‘polymath’ barely does him justice: a Colonel in the Medical Corps with an MPhil in poetry and apparently one of the “50 coolest people in...

Does turbinoplasty outcome vary in the presence of allergic disease?

This well organised study from Australia looks at inferior turbinoplasty outcomes in patients with allergy and non-allergic rhinitis who have become refractory to medical treatment. There were 190 patients undergoing turbinoplasty with or without septoplasty assessed in this case-control study...

Acute peripheral vestibulopathy: is it really neuritis?

The pathophysiology of acute vestibular dysfunction has been debated for decades. By seeking to clarify the underlying aetiology, this study muddies the waters further by advocating systemic and intratympanic steroids as first line treatment if the aetiology is uncertain. The...

Standardising outcome measures in chronic rhinosinusitis

This international paper, involving the foremost rhinology departments worldwide aims to provide a standardised, agreed core outcome set for chronic rhinosinusitis, which has been designed to facilitate future meta analyses of published work in systematic reviews. Stakeholders included patients, ENT...

Lockdown has been bad for children, but it might mean they don’t need surgery anymore

Our editor’s choice for this edition reviews an article looking at the effects of lockdown on symptom prevalence in children with adenotonsillar diseases. In this unprecedented COVID-19 era that we are all living and working in, risk assessment has taken...

Biologics for deafness

Cochlear implants and hearing aids are inherently limited in their ability to restore ‘natural’ hearing. Biological therapy to treat inner ear pathology still is evolving rapidly with several ongoing clinical trials, though none are available for clinical practice to date....

Outcomes of larger glottic cancer volumes treated with radiotherapy

T3 glottic cancer is characterised as vocal cord fixation and/or invasion into pre-epiglottic, post-cricoid, paraglottic spaces and/or within the inner cortex of thyroid cartilage. Traditionally, laryngectomy was considered the primary option to treat T3 laryngeal glottic cancers until other options...